Home > PB Ratio > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
PB (Price/Book ) Ratio

The Current P/B Ratio of SUN PHARMACEUTICAL INDUSTRIES is 6.82.

Share Price ₹1,808.8Nov 04,2024
Market Cap ₹433,985.4 Cr
Book Value₹63,666.8 CrMar2024 - Consolidated Results
Price/Book 6.82xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of SUN PHARMACEUTICAL INDUSTRIES

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of SUN PHARMACEUTICAL INDUSTRIES is calculated as :

Current Market Cap [ ₹433,985.4 Cr] as on Nov 04,2024

(/) Book Value [ ₹63,666.8 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 6.82x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for SUN PHARMACEUTICAL INDUSTRIES , the investors are currently willing to pay '6.82 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SUN PHARMACEUTICAL INDUSTRIES !

The chart below summarizes the trend in P/B Ratio of SUN PHARMACEUTICAL INDUSTRIES over the last five years.

Historical PB (Price/Book ) ratio chart of SUN PHARMACEUTICAL INDUSTRIES


PB Ratio Performance Analysis for SUN PHARMACEUTICAL INDUSTRIES

- SUN PHARMACEUTICAL INDUSTRIES 's latest p/b ratio is 6.82x.

- SUN PHARMACEUTICAL INDUSTRIES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.97x.

- SUN PHARMACEUTICAL INDUSTRIES 's operated at median p/b ratio of 4.21x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SUN PHARMACEUTICAL INDUSTRIES 's p/b ratio peaked in Mar2024 at 6.11x.

- SUN PHARMACEUTICAL INDUSTRIES 's p/b ratio hit its five-year low in Mar2020 of 1.87x.


How does SUN PHARMACEUTICAL INDUSTRIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
SUN PHARMACEUTICAL INDUSTRIES 63,666.806.82433,985.4
CIPLA LTD26,619.904.81127,968.0
DR REDDYS LABORATORIES LTD28,123.503.76105,796.0
ZYDUS LIFESCIENCES LTD19,829.505.10101,056.0
DIVIS LABORATORIES LTD13,571.0011.53156,498.0
MANKIND PHARMA LTD9,339.8411.73109,574.0
TORRENT PHARMACEUTICALS LTD6,856.1515.79108,250.0
LUPIN LTD14,175.807.0499,847.4
AUROBINDO PHARMA LTD29,842.802.7481,733.3
ABBOTT INDIA LTD3,658.7317.1162,599.5
ALKEM LABORATORIES LTD10,292.506.7369,302.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SUN PHARMACEUTICAL INDUSTRIES 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.74x
Max industry PB 17.11x
Median industry PB 6.82x
Average industry PB 8.47x



You may also like the below Video Courses